Thus, the present study aims to validate NAT2 as a myopia risk-associated gene and delves into its impact on scleral fibroblasts in myopia probably by regulating mitochondrial metabolism, which will provide novel insights and therapeutic avenues for the management of myopia. Here, NAT2 is linked to myopia.